Vincent Sibaud

25PUBLICATIONS
67CO-AUTHORS
Molecular targetsAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 10, 2026
Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations.

|Jun 08, 2026
Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study.

|Oct 30, 2025
Prevention and management of cutaneous immune-related adverse events: EADV Task Force statement.

Davide Fattore, Zoe Apalla, Azael Freites-Martinez

|Sep 09, 2025
Nail toxicities associated with cancer therapies: Insights and recommendations from the EADV task force dermatology for cancer patients.

Matilde Iorizzo, Francesca Pampaloni, Zoe Apalla

|Sep 09, 2025
Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.

Azael Freites-Martinez, Zoe Apalla, Jerry Shapiro

|Jul 21, 2025
Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance.

Kim A Papp, Luis Puig, Jennifer Beecker

Pageof 5

Frequent Collaborators

12 joint publications

Zoe Apalla

10 joint publications

Azael Freites-Martinez

8 joint publications

Davide Fattore

7 joint publications

Michela Valeria Rita Starace